Scientific Director - High Throughput Screening - Early Molecule Discovery
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world. The Lilly Small Molecule Discovery group is an organization purpose-built to create molecules that make life better for people. We focus on using cutting edge science to unlock new approaches that can treat people suffering from diseases with poor treatment options. We continually challenge ourselves to deliver molecules that can provide breakthrough efficacy with the highest possible safety margins. We are dedicated to optimizing our mindset, technology, and processes for faster, more nimble execution. Our success is built on a culture that empowers innovative problem solving through open collaboration and individual accountability. Position Summary: Lilly’s newly created Early Molecule Discovery team is responsible for small molecule hit to lead prosecution using traditional, and where warranted, novel mechanisms and technologies on early pre-portfolio targets. We are seeking an experienced drug hunter to lead our High Throughput Screening (HTS) efforts within the Ligand ID group. The candidate will direct a dynamic team focused on identifying and advancing small molecule drugs and implementing forward-thinking screening methods to expand Lilly’s early target portfolio.
